Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

350% Gainer Highlights 5 of Today’s Hottest Stocks

Wall Street is in the red today, as the markets await the first results of the meeting of the Federal Reserve that begins this afternoon. European stock markets remain weak, as do commodity prices and Asian stocks, where the markets fell after the Bank of Japan kept its monetary policy steady and offered a gloomier view of the country’s economy. However, there are several stocks gaining today, some of which are Solazyme Inc (NASDAQ:SZYM), Mead Johnson Nutrition CO (NYSE:MJN), Celator Pharmaceuticals Inc (NASDAQ:CPXX), Childrens Place Inc (NASDAQ:PLCE), and HD Supply Holdings Inc (NASDAQ:HDS). In the following article, we will examine why investors are buying these stocks and also examine the latest hedge fund activity in them.

Our backtests that covered the period between 1999 and 2012, showed that following the 15 most popular small-caps among hedge funds can help a retail investor beat the market by an average of 95 basis points per month (see more details here).

Solazyme Inc (NASDAQ:SZYM)’s stock has opened nearly 40% higher on the back of the company posting its financial results for the fourth quarter and full 2015 year. For the quarter ended December 31, Solazyme, now known as TerraVia, reported a revenue decline of 28.3% year-over-year to $10.4 million. Its loss grew to $0.32 per share, though this was smaller than expected. In addition to its quarterly and full year results, the food, nutrition and specialty ingredients company announced an agreement with Unilever plc (ADR) (NYSE:UL). The multi-year global supply contract allows Unilever to purchase renewable algae oils for use in personal care products and is expected to represent a total income of more than $200 million for Solazyme during its term. The agreement comes after last week’s announcement that Solazyme is refining its business to focus on food, nutrition and specialty ingredients, leveraging the power of its platform transformational innovation algae and renaming itself Terravia.

Among the funds we track, Solazyme Inc (NASDAQ:SZYM) was not very popular, with only six funds reporting long positions equal to 8.0% of the company’s shares as of the end of December. John Burbank’s Passport Capital was the top shareholder of the stock in our database, with 6.00 million shares held on December 31.

Follow Terravia Holdings Inc. (NASDAQ:TVIA)
Trade (NASDAQ:TVIA) Now!

Second on our list of some of the day’s biggest gainers is Mead Johnson Nutrition CO (NYSE:MJN), whose shares are up by 9% after it was reported that the company is working with Lazard regarding a potential merger, after news that European rivals Nestle and Danone expressed an interest in acquiring the company. This is not the first time the company has been discussed as a potential acquisition target.

Of the 785 elite funds that we track, 38 funds were long Mead Johnson Nutrition CO (NYSE:MJN) on December 31, with their positions amounting to 7.10% of the company’s float. Among the bulls is Ken Fisher‘s Fisher Asset Management, with a holding of 1.76 million shares.

Follow Mead Johnson Nutrition Co (NYSE:MJN)
Trade (NYSE:MJN) Now!

The second page has the details on three more stocks, including one that is up by over 300% today.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
This is a FREE report from Insider Monkey. Credit Card is NOT required.